Algorics的封面图片
Algorics

Algorics

生物技术研究

Bethesda,Maryland 9,364 位关注者

A Precision for Medicine Company

关于我们

In March 2024, Algorics was acquired by Precision for Medicine. Over the years Algorics has enjoyed significant success and growth, supporting clients globally with clinical data services, cutting-edge clinical technologies and agile resourcing solutions. As we step into the future as part of Precision for Medicine, we become part of the first biomarker-driven clinical research and development services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. With Precision’s transformational approach to clinical research that integrates clinical trial design and execution with deep scientific knowledge, laboratory expertise, data intelligence and advanced manufacturing solutions, we bring life-saving treatments to patients who need them the most. Precision for Medicine is part of Precision Medicine Group, with 3,500 people in 40 locations globally across North America, Europe and Asia-Pacific. For more information, visit www.precisionformedicine.com

网站
https://www.precisionformedicine.com
所属行业
生物技术研究
规模
51-200 人
总部
Bethesda,Maryland
类型
私人持股
创立
2013
领域
Analytics、Clinical research analytics、Biostatistics、Data standardization、Statistical programming、Metadata、Regulated software、SAS、Data aggregation、Data visualization 、Data science和AI/ML

地点

  • 主要

    2 Bethesda Metro Center

    US,Maryland,Bethesda,20814

    获取路线
  • 111 Speen St

    US,Massachusetts,Framingham,01701

    获取路线

Algorics员工

动态

  • 查看Algorics的组织主页

    9,364 位关注者

    Algorics is excited to announce we have been acquired by Precision For Medicine, a global leader in biomarker-driven clinical research and development supporting life sciences companies. "We are proud to join Precision for Medicine, a company that shares our commitment to leveraging data and technology to optimize clinical development and improve patient outcomes,” said Nithiya Ananthakrishnan, Founder and Chief Executive Officer of Algorics and now Senior Vice President of Biometrics with Precision for Medicine. With the integration of our technologies and staff into Precision for Medicine, we see a unique opportunity to leverage our combined strengths and expertise to accelerate clinical development and enhance patient outcomes. Read the full press release to learn more: https://lnkd.in/g3U7uMch To read on our website: https://lnkd.in/gke4nhDr

    • 该图片无替代文字
  • 查看Algorics的组织主页

    9,364 位关注者

    Excellent initiative by IASCT Organization to bring together the best of the industry and academia. It is opportunities like these that truly bridge academic outcomes with industry needs. Particularly, bringing forth how internship programs are effective in nurturing emerging talent for the clinical data community was a super impactful session. Glad Nathiya Natarajan could participate and contribute to this discussion. Look forward to participating in many more engagements with academia brought together by IASCT Organization #clinicalresearch #industry #clinicaldata #academia #futureworkforce

    查看IASCT Organization的档案

    Indian Association for Statistics in Clinical Trials

    We are thrilled to celebrate the success of the Industry-Academic Connect at SRM University, a pivotal event aimed at fostering stronger ties between industry and academia. The gathering was nothing short of remarkable, featuring engaging discussions, insightful presentations, and the convergence of industry leaders, educators, and eager students. It created a powerful platform for meaningful dialogue and collaboration. This momentous occasion was graced by renowned speakers who delivered captivating presentations, including "Life Cycle of Drug Development: An Overview of Clinical Trials," "Overview of different regulators and types of applications," "Career options in the Pharma Industry: Biostatistics, Statistical Programmer, Data Analyst / Data Scientist," and "The Applications of Artificial Intelligence (AI) and Machine Learning (ML) in the Pharmaceutical Industry: How Digital Transformation is impacting the Pharma Industry?" Their expertise and passion left a lasting impact, inspiring all participants and enriching the event. We extend our heartfelt gratitude to the moderators Jagadish Suriyanarayanan and Jayapandian Nagamalaiyan for steering insightful and engaging panel discussions on "Forging Partnerships: Enhancing Collaboration between Industry and Academia" and "Exploring Statistical Programming and Data Science in Pharmaceutical Organizations and CROs: An Intern's Perspective." A resounding thank you goes out to our esteemed speakers Mahesh Iyer, Gauravbir Dogra, Anitha Cecelia, Padmanaban Sambatkumar, Dr Vadivu G, Parthiban S D, Rajalakshmi Srinivasan, Dr. Solomon F.D. Paul, Srinivasa Raghavan Ranganathan, Nathiya Natarajan, Phanindra Kumar Mandamala, Surabhi Chaudhari, VIBIN M, SRM, and the enthusiastic students, all of whom contributed significantly to making this event a remarkable success. Together, let's continue to build bridges that connect our academic prowess with real-world industry insights. We also extend a special thanks to Akhila Edathala, Nitin Nayak, Vinaykrishna Thatta, Franklin Moses and the website team for their tireless efforts in branding the event, ensuring its visibility and success. Lastly, we express our deep appreciation to the Executive Committee members Ashish Charles, Dr. Pooja Shinde (PT), Nishanth Nalan, Jagannath P S, Surendra Yajamanam, Rashmi Jain, and Sucharita Pilli for their guidance and coordination this event. As we move forward, we are committed to nurturing and strengthening these connections, providing valuable opportunities for growth, learning, and innovation. #IndustryAcademicConnect #Collaboration

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
      +10

关联主页

相似主页

查看职位